The Influence of Splenectomy Performed Simultaneously with Gastrectomy on Postoperative Complications in Patients with Gastric Cancer Undergoing Surgery with the Intention to Treat
Languages of publication
Despite the growing understanding of the pathophysiological processes in the perioperative period and significant advancements in surgical techniques, operative treatment for gastric cancer remains a challenge for surgeons, especially because the primary procedure of total or nearly total gastrectomy must at times be extended by the resection of other organs. The aim of the study was to asses the influence of concomitant splenectomy in patients undergoing curative surgery for gastric cancer on postoperative complications. Material and methods. The study population consisted of 258 patients who underwent surgical treatment for gastric cancer with the intention to treat. The study assessed the influence of extending the surgical intervention by splenectomy on postoperative complications, both general and surgical, including the most severe of these, i.e. oesophago-gastric anastomotic leakage, duodenal stump leakage and peritoneal fluid infections. Results. Among the 258 gastric cancer patients receiving curative surgical treatment, the most common simultaneous intervention was splenectomy: 42/258 (16.3%), which was also accompanied by partial pancreatectomy in 8 cases. The number of surgical postoperative complications, major and minor, was similar in both subgroups: with and without splenectomy. Minor general complications, such as pyrexia with no clinically apparent reason, atelectasis, pneumonia and pleural effusion were statistically significantly more common in the subgroup with splenectomy (p=0.0001). Conclusion. Splenectomy performed concomitantly with gastrectomy for gastric cancer increases the risk of minor general complications. However, it does not increase the risk of severe surgical complications, such as oesophago-intestinal anastomotic leakage and does not increase the risk of death
1 - 7 - 2014
12 - 9 - 2014
21 - 6 - 2014
- 1. Krajowy Rejestr Nowotworów - dostępny pod adresem: http://epid.coi.waw.pl/krn/
- 2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide in-cidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
- 3. Stewart BW, Kleihues P: World Cancer Report. Lyon: IARC Press; 2003.
- 4. Lutz MP, Zalcberg JR, Ducreux M et al.: Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer. Differential treatment strategies for subtypes of early gastroesophageal cancer. Eur J Cancer 2012; 48(16): 2941-53.[WoS][PubMed][Crossref]
- 5. Olszewska M, Głuszek S: New possibilities for the treatment of gastric cancer. Studia Medyczne 2013; 29(4): 343-48.[Crossref]
- 6. Fujimoto S, Akao T, Itol B et al.: A study of survival in patients with stomach cancer treated by a combination of preoperative intra-arterial infusion therapy and surgery. Cancer 1976; 37(4): 1648-53.[PubMed][Crossref]
- 7. Wilke H, Preusser P, Fink U et al.: Preoperative chemotherapy in locally advanced and nonresectable gastriccancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 1989; 7(9): 1318-26.
- 8. Cuscheri A, Weeden S, Fielding J et al.: Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC ranomized surgical trial. Br J Cancer 1999; 79(9-10): 1522-30.
- 9. Bonenkamp JJ, Hermans J, Sasako M et al.: Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340(12): 908-14.
- 10. Stojcev Z, Bobowic M, Jarząb M i wsp.: Chorobowość, śmiertelność i przeżycie po resekcji żołądka ze splenektomią lub bez splenektomii - obserwacje w jednym ośrodku. Pol Przegl Chir 2013; 85(8): 433-47.
- 11. Brady MS, Rogatko A, Dent LL et al.: Effect of splenectomy on morbidity an survival following curative gastrectomy for carcinoma. Arch Surg 1991; 126(3): 359-64.[PubMed][Crossref]
- 12. Dindo D, Demartines N, Clavien PA: Classification of Surgical Complications. A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey. Ann Surg 2004; 240(2): 205-13.
- 13. Ito H, Inoue H, Odaka N et al.: Prognostic Impact of Prophylactic Splenectomy for Upper-third Gastric Cancer: A Cohort Study. Anticancer Res 2013; 33(1): 277-82.[PubMed]
- 14. Nashimoto A, Yabusaki H, Matsuki A: The significance of splenectomy for advanced Proximal gastric cancer. Int J Surg Oncol 2012; 301530: doi:10.1155/2012/301530.[PubMed][Crossref]
- 15. Papenfuss WA , Kukar M, Oxenberg J et al.: Morbidity and mortality associated with gastrectomy for gastric cancer. Ann Surg Oncol 2014; (w druku).
- 16. Głuszek S, Kot M: Risk factors of postoperative complications after curative surgery in gastric cancer. Nowotwory 2004; 54: 238-48.
- 17. Yang K, Chen XZ, Hu JK et al.: Effectiveness and safety of splenectomy for gastric carcinoma: A meta-analysis. World J Gastroenterol 2009; 15(42): 5352-59.[Crossref][PubMed]
- 18. Kulig J, Wallner G, Drews M i wsp.: Polish consensus on treatment of gastric cancer; update 2013; Pol Przegl Chir 2013; 85(9): 544-62.
- 19. Weitz J, Jaques DP, Brennan M et al.: Association of Splenectomy With Postoperative Complications in Patients With Proximal Gastric and Gastroesophageal Junction Cancer. Ann Surg Oncol 2004; 11(7): 682-89.[Crossref][PubMed]
- 20. Sano T, Yamamoto S, Sasako M: Japan ClinicalOncology Group Study LCOG 0110-MF. Randomizedcontrolled trial to evaluate splenectomy in totalgastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF. Jpn J Clin Oncol 2002; 32(9): 363-64.
Publication order reference